Quick Summary
Sorafeb 200mg Tablet 30's
Last updated on 26 Sep 2026 | 08:41 AM (IST)
₹1439
MRP: ₹2190
(You Save ₹751)
30 TABLET(s) IN A BOTTLE
34% OFF
₹1439
MRP: ₹2,190.00
Inclusive of all taxes
34% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Soranamo 200mg Tablet
SHIVNAAM TRADEL...
₹ 25.24/tablet
47% cheaper
Livonibe 200mg Tablet
BDR PHARMACEUTI...
₹ 28.82/tablet
39% cheaper
Soralieva 200mg Tablet
Allieva Pharma ...
₹ 31.14/tablet
35% cheaper
Sorafekast 200mg Tablet 30's
APRAZER HEALTHC...
₹ 31.70/tablet
33% cheaper
Better Service Satisfied Customers
Introduction to Sorafeb 200mg Tablet 30's
Sorafeb 200mg Tablet 30's belongs to the class of cancer medications known as multikinase inhibitors, containing the active ingredient sorafenib. Sorafeb 200mg Tablet 30's is a medication primarily used in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and thyroid cancer.
It is not recommended to take Sorafeb 200mg Tablet 30's if you are allergic to the active compound and other ingredients of the medicine. Speak with your doctor immediately if you experience skin rashes, heart problems, chest pain, bleeding problems, high blood pressure, or have had or are about to have surgery. It is not recommended for use in children and adolescents. Patients with diabetes should have their blood sugar levels examined frequently to see whether the dosage of anti-diabetic medications needs to be changed to reduce the risk of low blood sugar. Your doctor will monitor liver function tests, fluid and electrolyte balance to help identify and manage potential side effects promptly.
It is not advised to use this medication while pregnant since it may harm the fetus. Therefore, for women of reproductive age, it is recommended to get a pregnancy test before beginning this medication. It is preferable to keep using birth control for at least six months after treatment is finished. While receiving treatment, it is not advised to breastfeed your child because this medication might affect your baby's growth and development. This treatment may affect the fertility in both men and women, it is advised to consult your doctor before starting the therapy.
It is necessary to inform your doctor about all the medicines you are taking including prescription, over-the-counter drugs, vitamins and supplements.
Uses of Sorafeb 200mg Tablet 30's
- Advanced renal cell carcinoma
- Advanced hepatocellular carcinoma
- Differentiated thyroid carcinoma
Therapeutic Effects of Sorafeb 200mg Tablet 30's
Sorafeb 200mg Tablet 30's works by inhibiting multiple protein kinases involved in tumour cell proliferation and angiogenesis (the formation of new blood vessels that supply tumours). Specifically, it targets receptors for vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and Raf kinases, which play key roles in cancer development and progression. This stops the growth and spread of the tumour cells to other organs, as well as the formation of blood vessels in the tumour cells.
Interaction of Sorafeb 200mg Tablet 30's with other drugs
Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Sorafeb 200mg Tablet 30's and reduce its effectiveness by causing undesirable side effects.
More Information about Sorafeb 200mg Tablet 30's
- Store Sorafeb 200mg Tablet 30's in the original package at room temperature (20°C to 25°C).
- Keep it out of reach of children.
How to consume Sorafeb 200mg Tablet 30's
The medicine will be prescribed to you by a healthcare professional in a hospital setting. It is not recommended to take this medication with meals that are high in fat since this may reduce Sorafeb 200mg Tablet 30's's effectiveness. Take the pills at least one hour before or two hours after a high-fat meal if you plan to eat one. The dose will be decided by your healthcare professional based on your condition. Avoid crushing, opening, or dissolving the tablet and swallow it whole with a glass of water. Take the Sorafeb 200mg Tablet 30's at the same time every day.
Safety Advice for Sorafeb 200mg Tablet 30's
Breast Feeding
It is unknown whether Sorafeb 200mg Tablet 30's passes into the breast milk. It is not recommended to nurse a child during the therapy. This medication might affect your baby's growth and development. Please consult your doctor before breastfeeding.
Alcohol
Alcohol consumption can lead to hepatotoxicity and might alter the metabolism of Sorafeb 200mg Tablet 30's. Please consult your doctor for more advice.
Liver
It is unknown whether Sorafeb 200mg Tablet 30's is safe in individuals with liver disorders. Inform your physician if you have any liver problems before starting the treatment.
Lungs
Consult your doctor if you have any lung diseases before starting the treatment with Sorafeb 200mg Tablet 30's.
Driving
There is no proof that Sorafeb 200mg Tablet 30's will impair one's capacity to operate machinery or drive a car. However, if you experience any of the side effects like dizziness, fatigue, it is not advised to drive or operate heavy machinery.
Pregnancy
It is not recommended to take Sorafeb 200mg Tablet 30's during pregnancy as it may harm your unborn baby. It is necessary to inform your doctor if you are pregnant or planning to become pregnant.
Side Effects of Sorafeb 200mg Tablet 30's
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious:
- gastrointestinal perforation
- abnormal heart rhythm (QT prolongation)
- Inflammation of the liver
- breathing or swallowing difficulties
- Stevens-Johnson Syndrome and toxic epidermal necrolysis
- Decreased blood flow to the heart
- Increased risk of bleeding (blood in urine, stool, vomit, cough)
Common:
- Nausea
- Vomiting
- Fatigue
- Diarrhoea
- Alopecia
- Hand-foot skin reaction
- Gut wall bleeding
Word of Advice
Follow all instructions and dosing recommendations provided by your healthcare provider. Do not take more or less of the medication than prescribed. Report any new or worsening symptoms to your healthcare provider immediately, especially if they relate to your lungs, eyes, skin, liver, kidneys, heart, or bleeding. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. Sorafeb 200mg Tablet 30's should not be stopped without first talking to your doctor. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping Sorafeb 200mg Tablets 30's. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhoea and other gastrointestinal disorders.
Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately.
FAQs about Sorafeb 200mg Tablet 30's
Q1.
Will Sorafeb 200mg Tablet 30's cause hair loss?
Alopecia, or hair thinning or loss, is a possible adverse effect of Sorafeb 200mg Tablet 30's therapy. However, it is less frequent than with certain other chemotherapy medications. While using Sorafeb 200mg Tablets 30's, not every patient will experience hair loss, and each patient's level of hair thinning will differ.
Q2.
Can individuals with diabetes take a Sorafeb 200mg Tablet 30's?
The decision to use Sorafeb 200mg Tablet 30's in individuals with diabetes should be made on a case-by-case basis. Sorafeb 200mg Tablet 30's may affect blood glucose levels, and individuals with diabetes may experience changes in glycemic control while taking the medication.
Q3.
For what duration must you take a Sorafeb 200mg Tablet 30's?
The length of Sorafeb 200mg Tablet 30's treatment varies based on patient-specific factors such as tolerability, treatment response, and cancer kind and stage. At the same time, some individuals would only need Sorafeb 200mg Tablet 30's for a few months, others might need ongoing care. The length of treatment that is right for you will be decided by your healthcare practitioner based on your particular circumstances.
Fact Box of Sorafeb 200mg Tablet 30's
Molecule Name: Sorafenib
| Therapeutic Class: Antineoplastics |
| Pharmacological class: Multikinase inhibitors | Indications: 1. Advanced renal cell carcinoma 2. Advanced hepatocellular carcinoma 3. Differentiated thyroid carcinoma |
| Dosage form: Tablets | Habit forming: No
|
References
- Bayer (Pty) Ltd, [Revised on 22nd Apr 2016] [Accessed on 15th March 2024], https://www.bayer.com/sites/default/files/NEXAVAR_200_EN_PI.pdf
- Bayer HealthCare Pharmaceuticals Inc., US Food & Drug Administration, [Revised on Dec 2018] [Accessed on 15th March 2024]], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021923s020lbl.pdf
- Bayer AG, European Medicines Compendium (emc), [Revised on April 2023], [Accessed on 15th March 2024], https://www.medicines.org.uk/emc/files/pil.226.pdf
- Zentiva Pharma UK Limited, Medicines Compendium (emc), [Revised on April 2022], [Accessed on 15th March 2024] https://www.medicines.org.uk/emc/files/pil.13098.pdf
- KD Tripathi, Anticancer Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 915-936.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and content of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details

Written By
Dr. Vijayalakshmi N.
BDS

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 26 Sep 2026 | 08:41 AM (IST)

Want to know more?
Read Our Editorial Policy







